Drawing for CU BO CURCUMIN BOSWELLIA

USPTO serial 79381593

CU BO CURCUMIN BOSWELLIA

Reviewed by CopyMark Law Group

Reg. 7942998Status 700Registered
Filing date
Status date
Registration date
Sep 16, 2025
Examiner
VOHRA, SANJEEV KUMAR
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CU BO CURCUMIN BOSWELLIA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Robert S. Broder

Robert S. Broder Collard & Roe, P.C.1077 Northern Blvd.Roslyn, NY 11576United States

Goods and services

ClassDescriptionStatusFirst use
001Active chemical ingredients for use in the manufacture of pharmaceuticals for treating of gastrointestinal diseases, abdominal bloating, cardiovascular system diseases, gastroenteric system diseases, respiratory system diseases, immune and endocrine system diseases, chronic inflammatory diseases, skin diseases, urinary tract diseases, musculoskeletal disorders, metabolic diseases, ocular diseases, peripheral nervous disorders, ageing disorders, liver diseases, chronic fatigue syndrome, dietary supplements and dietetic preparations, all containing curcumin and boswellia; Chemical preparations for the manufacture of pharmaceuticals, dietary supplements and dietetic preparations, for treating of gastrointestinal diseases, abdominal bloating, cardiovascular system diseases, gastroenteric system diseases, respiratory system diseases, immune and endocrine system diseases, chronic inflammatory diseases, skin diseases, urinary tract diseases, musculoskeletal disorders, metabolic diseases, ocular diseases, peripheral nervous disorders, ageing disorders, liver diseases, chronic fatigue syndrome, all containing curcumin and boswellia; Chemical additives for use in the manufacture of food, all containing curcumin and boswellia.ACTIVE—
005Pharmaceutical preparations for the treatment of gastrointestinal diseases, abdominal bloating, cardiovascular system diseases, gastroenteric system diseases, respiratory system diseases, immune and endocrine system diseases, chronic inflammatory diseases, skin diseases, urinary tract diseases, musculoskeletal disorders, metabolic diseases, ocular diseases, peripheral nervous disorders, ageing disorders, liver diseases, chronic fatigue syndrome diseases, all containing curcumin and boswellia; dietary supplements and dietetic preparations, all containing curcumin and boswellia; Plant and herb extracts, other than essential oils, for medicinal purposes, all containing curcumin and boswellia.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 16, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 27, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 27, 2026FIMPFINAL DISPOSITION PROCESSED—
Dec 16, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 16, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 16, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 29, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 29, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 23, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 24, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 30, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 30, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 30, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 3, 2025RFNTREFUSAL PROCESSED BY IB—
Apr 15, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 15, 2025RFRRREFUSAL PROCESSED BY MPU—
Apr 12, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 25, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 25, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
May 30, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 29, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 24, 2024RFWRNON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW—
May 16, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 15, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 3, 2024DOCKASSIGNED TO EXAMINER—
Oct 31, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 27, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 26, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance